DYNAVAX TECHNOLOGIES CORPDVAXEarnings & Financial Report
Nasdaq
NextMar 25, 2026
DVAX Q3 2025 Key Financial Metrics
Revenue
$94.9M
Gross Profit
N/A
Operating Profit
$21.3M
Net Profit
$26.9M
Gross Margin
N/A
Operating Margin
22.4%
Net Margin
28.4%
YoY Growth
17.7%
EPS
$0.21
Financial Flow
DYNAVAX TECHNOLOGIES CORP Q3 2025 Financial Summary
DYNAVAX TECHNOLOGIES CORP reported revenue of $94.9M for Q3 2025, with a net profit of $26.9M (28.4% margin). Cost of goods sold was N/A, operating expenses totaled N/A.
Key Financial Metrics
| Total Revenue | $94.9M |
|---|---|
| Net Profit | $26.9M |
| Gross Margin | N/A |
| Operating Margin | 22.4% |
| Report Period | Q3 2025 |
DYNAVAX TECHNOLOGIES CORP Annual Revenue by Year
DYNAVAX TECHNOLOGIES CORP annual revenue history includes year-by-year totals (for example, 2024 revenue was $277.2M).
| Year | Annual Revenue |
|---|---|
| 2024 | $277.2M |
| 2023 | $232.3M |
| 2022 | $722.7M |
Income Statement
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $55.6M | $50.8M | $73.8M | $80.6M | $72.0M | $68.2M | $95.4M | $94.9M |
| YoY Growth | -69.9% | 8.2% | 22.5% | 16.0% | 29.6% | 34.2% | 29.3% | 17.7% |
Balance Sheet
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $997.1M | $986.6M | $1.02B | $1.06B | $986.3M | $945.9M | $918.4M | $946.5M |
| Liabilities | $375.0M | $368.1M | $373.5M | $380.6M | $389.5M | $415.0M | $424.3M | $412.4M |
| Equity | $622.1M | $618.5M | $642.8M | $681.4M | $596.8M | $530.9M | $494.2M | $534.1M |
Cash Flow
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $13.8M | $-16.7M | $10.7M | $19.5M | $53.0M | $-19.6M | $23.4M | $33.8M |